| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC SODIUM | 7114 |
| 1 | TIRZEPATIDE | 1332 |
| 2 | DICLOFENAC | 802 |
| 3 | MINOXIDIL | 769 |
| 4 | DICLOFENAC SODIUM 1% | 733 |
| 5 | DICLOFENAC SODIUM TOPICAL | 733 |
| 6 | DICLOFENAC SODIUM TOPICAL GEL, 1% | 733 |
| 7 | MINOXIDIL FOAM 5% (WOMENS) | 674 |
| 8 | DUPILUMAB | 617 |
| 9 | DULAGLUTIDE | 517 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APPLE CIDER VINEGAR ANTI-DANDRUFF LEAVE-IN | 1 | 1.0000 |
| 1 | CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% | 3 | 0.1875 |
| 2 | ALUMINUM CHLOROHYDRATE | 5 | 0.1111 |
| 3 | CALCIPOTRIENE CREAM, 0.005% | 10 | 0.0971 |
| 4 | ATEZOLIZUMAB AND HYALURONIDASE-TQJS | 2 | 0.0833 |
| 5 | MENADIONE | 10 | 0.0719 |
| 6 | ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY | 2 | 0.0556 |
| 7 | ARIPIPRAZOLE LAUROXIL | 219 | 0.0475 |
| 8 | DICLOFENAC SODIUM | 7114 | 0.0469 |
| 9 | TRASTUZUMAB AND HYALURONIDASE-OYSK | 4 | 0.0374 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 26 | 0.0378 |
| 1 | PCSK9 Inhibitor [EPC] | 658 | 0.0256 |
| 2 | Endoglycosidase [EPC] | 40 | 0.0216 |
| 3 | Thyroid Stimulating Hormone [EPC] | 21 | 0.0202 |
| 4 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 5 | Cytolytic Agent [EPC] | 27 | 0.0116 |
| 6 | Pyrethroid [EPC] | 19 | 0.0108 |
| 7 | Parathyroid Hormone-Related Peptide Analog [EPC] | 321 | 0.0103 |
| 8 | Arteriolar Vasodilator [EPC] | 785 | 0.0100 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 702 | 0.0068 |